Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome

Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome

Cardiorenal syndrome encompasses a spectrum of disorders involving heart and kidney dysfunction, and sharing common risk factors, such as hypertension and diabetes. Clinical studies have shown that patients with and without diabetes may benefit from using sodium-glucose cotransporter 2 inhibitors to...

Full description

Saved in:
Bibliographic Details
Main Authors: Konrad Urbanek, Donato Cappetta, Gabriella Bellocchio, Maria Antonietta Coppola, Paola Imbrici, Marialucia Telesca, Maria Donniacuo, Maria Antonietta Riemma, Elena Mele, Eleonora Cianflone, Silvio Naviglio, Elena Conte, Giulia Maria Camerino, Marco Mele, Mariarosaria Bucci, Giuseppe Castaldo, Annamaria De Luca, Francesco Rossi, Liberato Berrino, Antonella Liantonio, Antonella De Angelis
Format: Artigo
Language:English
Published: 2023
Online Access:https://doi.org/10.1016/j.phrs.2023.106659
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1016/j.phrs.2023.106659

Similar Items